Several batches of Torrent Pharma’s Dutor (duloxetine) Gastro-resistant Capsules, Hard, are in a Class 3 drugs recall issued on Monday.
The affected batches are as follows:
|Strength||Batch Number||Expiry Date||Pack Size||First Distribution|
|20mg||BAC5C001||31 Oct 2017||1 x 56||Jun 2016|
|20mg||BAC5C002||31 Jul 2018||1 x 28||Jan 2017|
|20mg||BAC5C005||31 Aug 2018||1 x 28||Feb 2017|
|30mg||BAC3C001||31 Oct 2017||1 x 28||Sep 2016|
|30mg||BAC3C002||31 Oct 2017||1 x 28||Jun 2016|
|30mg||BAC3C007||31 Aug 2018||1 x 28||Feb 2017|
|40mg||BAC4C001||31 Oct 2017||1 x 56||Jun 2016|
|40mg||BAC4C004||31 Aug 2018||1 x 56||Jan 2017|
|60mg||BAC6C001||31 Oct 2017||1 x 28||Jun 2016|
|60mg||BAC6C003||31 Jul 2018||1 x 28||May 2017|
The recall is precautionary as routine stability testing found dissolution rates were outside of the normal specifications.
Affected stock should be quarantined and returned to the original supplier for credit.
Further information can be obtained from Torrent Pharma – contact Lee Ford on 01293 574184 for stock enquiries or Josephine Ayella on 01293 574183 for medical information.